Warning
SCOPE HEALTH Recalls Optase Dry Eye Intense Drops (Glycerin 0.2%)
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0499-2026Drug / Pharmaceutical
SCOPE HEALTH Recalls Optase Dry Eye Intense Drops (Glycerin 0.2%)
SCOPE HEALTH · Class II — Moderate Risk
Product Description
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
Reason for Recall
Lack of Assurance of Sterility
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the United States
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. SCOPE HEALTH initiated the recall on April 20, 2026. Lack of Assurance of Sterility. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact SCOPE HEALTH for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.